A case-control study investigating food addiction in Parkinson patients.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 05 2021
25 05 2021
Historique:
received:
20
07
2020
accepted:
18
03
2021
entrez:
26
5
2021
pubmed:
27
5
2021
medline:
4
11
2021
Statut:
epublish
Résumé
Eating disorders (EDs) in patients with Parkinson's disease (PD) are mainly described through impulse control disorders but represent one end of the spectrum of food addiction (FA). Although not formally recognized by DSM-5, FA is well described in the literature on animal models and humans, but data on prevalence and risk factors compared with healthy controls (HCs) are lacking. We conducted a cross-sectional study including 200 patients with PD and 200 age- and gender-matched HCs. Characteristics including clinical data (features of PD/current medication) were collected. FA was rated using DSM-5 criteria and the Questionnaire on Eating and Weight Patterns-Revised (QEWP-R). Patients with PD had more EDs compared to HCs (27.0% vs. 13.0%, respectively, p < 0.001). They mainly had FA (24.5% vs. 12.0%, p = 0.001) and night eating syndrome (7.0% vs. 2.5% p = 0.03). In PD patients, FA was associated with female gender (p = 0.04) and impulsivity (higher attentional non-planning factor) but not with the dose or class of dopaminergic therapy. Vigilance is necessary, especially for PD women and in patients with specific impulsive personality traits. Counterintuitively, agonist dopaminergic treatment should not be used as an indication for screening FA in patients with PD.
Identifiants
pubmed: 34035366
doi: 10.1038/s41598-021-90266-8
pii: 10.1038/s41598-021-90266-8
pmc: PMC8149641
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10934Références
Mov Disord. 2006 Apr;21(4):524-9
pubmed: 16261618
Int Psychogeriatr. 2010 Jun;22(4):523-36
pubmed: 20170590
J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):56-62
pubmed: 21304139
J Hum Nutr Diet. 2018 Aug;31(4):544-572
pubmed: 29368800
Lancet Neurol. 2014 Mar;13(3):287-305
pubmed: 24556007
Drug Saf. 2018 Jan;41(1):19-75
pubmed: 28861870
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):868-74
pubmed: 23447648
Biol Psychiatry. 2013 May 1;73(9):904-14
pubmed: 23290497
Neuropsychopharmacology. 2018 Dec;43(13):2506-2513
pubmed: 30188514
Can J Psychiatry. 2014 May;59(5):276-84
pubmed: 25007281
Psychiatry Res. 2014 Sep 30;223(3):244-52
pubmed: 24969539
Brain. 2012 May;135(Pt 5):1463-77
pubmed: 22508959
Appetite. 2009 Apr;52(2):430-6
pubmed: 19121351
Eur Eat Disord Rev. 2018 Nov;26(6):574-584
pubmed: 30159982
Int J Eat Disord. 2004 Dec;36(4):434-44
pubmed: 15558644
Eat Weight Disord. 2019 Jun;24(3):421-429
pubmed: 30715681
Nutrients. 2014 Sep 16;6(9):3653-71
pubmed: 25230209
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Sleep Med. 2018 Aug;48:148-154
pubmed: 29913341
Mov Disord. 2011 Apr;26(5):830-6
pubmed: 21370268
Mov Disord. 2015 Feb;30(2):141-9
pubmed: 25476402
Nat Rev Neurosci. 2017 Nov 16;18(12):741-752
pubmed: 29142296
Appetite. 1990 Dec;15(3):231-46
pubmed: 2281953
PLoS Med. 2007 Oct 16;4(10):e296
pubmed: 17941714
J Psychopharmacol. 2007 Jul;21(5):501-6
pubmed: 17446202
Int J Eat Disord. 1997 Jul;22(1):65-9
pubmed: 9140737
J Addict Med. 2009 Mar;3(1):1-7
pubmed: 21768996
J Nutr. 2003 Mar;133(3):835S-837S
pubmed: 12612163
Mov Disord. 2019 Jun;34(6):767-768
pubmed: 31206832
Neurosurg Focus. 2015 Jun;38(6):E8
pubmed: 26030708
Int J Eat Disord. 2017 Jul;50(7):793-800
pubmed: 28301060
Nutrients. 2018 Apr 12;10(4):
pubmed: 29649120
Front Neurol. 2018 May 22;9:330
pubmed: 29872418
Arch Gen Psychiatry. 2011 Aug;68(8):808-16
pubmed: 21464344
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Addict Behav. 1995 Nov-Dec;20(6):733-45
pubmed: 8820526
Behav Sci (Basel). 2017 Aug 14;7(3):
pubmed: 28805749
Mov Disord. 2015 Feb;30(2):121-7
pubmed: 25370355
Psychol Addict Behav. 2016 Feb;30(1):113-21
pubmed: 26866783
Pharm World Sci. 2010 Apr;32(2):114-6
pubmed: 20039208
Curr Drug Abuse Rev. 2011 Sep;4(3):174-81
pubmed: 21999691
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1338-43
pubmed: 15278102
Med Hypotheses. 2009 May;72(5):518-26
pubmed: 19223127
J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):1019-21
pubmed: 22752694
Compr Psychiatry. 2017 Jan;72:83-87
pubmed: 27768944
J Addict Med. 2009 Mar;3(1):26-32
pubmed: 20473361
Eur Neuropsychopharmacol. 2016 Apr;26(4):644-52
pubmed: 26944295
Parkinsonism Relat Disord. 2011 May;17(4):295-6
pubmed: 21300562
Obes Res. 1993 Jul;1(4):306-24
pubmed: 16350580
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Front Neurol. 2014 Jun 02;5:84
pubmed: 24917848
Mov Disord. 2015 Apr 15;30(5):705-13
pubmed: 25809278
Eat Behav. 2005 Feb;6(2):119-25
pubmed: 15598598
Int Rev Neurobiol. 2017;133:623-655
pubmed: 28802935
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S24-S29
pubmed: 28818561
Nutrients. 2014 Oct 21;6(10):4552-90
pubmed: 25338274
Arch Neurol. 2010 May;67(5):589-95
pubmed: 20457959
Curr Opin Psychiatry. 2017 Nov;30(6):446-451
pubmed: 28825955